biotech
Pfizer Acquires Rinat Neuroscience Corp.
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on April 13, 2006
Pfizer Acquires Rinat Neuroscience Corp.
Pfizer expands its neuroscience research as it announces its plans to acquire Rinat Neuroscience Corp., a privately held spin-off from Genentech, which develops treatments for diseases and disorders of the central nervous system.

"Rinat is a pioneer in developing protein-based therapeutics and we see tremendous potential in its research to develop new medicines, notably for the treatment of Alzheimer's disease. Combining Rinat's potential product portfolio with Pfizer's capabilities is a further step in our strategy to enhance Pfizer's internal research and development efforts with high-potential, externally sourced product candidates and technologies."


Some of the compounds in Rinat's pipeline are RN624, a nerve growth factor inhibitor for treatment of acute and chronic pain (currently entering Phase II clinical trials) and RN1219, a humanized monoclonal antibody for the potential treatment of Alzheimer's disease.

Permalink: Pfizer Acquires Rinat Neuroscience Corp.
Tags: alzheimer  acquisition  biotech  rinat  pfizer  neuroscience+corp  rinat+neuroscience  pfizer+acquires 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20024
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Pfizer Acquires Rinat Neuroscience Corp.:

  • Currently 8.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.50 out of 4 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!